Plain-English translation of NCT07299292 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether abiraterone, a hormone-blocking medication taken by mouth, can lower testosterone to castration levels (very low) within 30 days without also needing hormone-blocking injections. Right now, men with advanced prostate cancer usually receive both abiraterone and injections together. Researchers want to see if the medication alone can work just as well for this critical first month.
In Argentina and Bolivia, patients often wait more than two months to access the full combination treatment they need. This trial explores whether using this medication alone for the first month could get patients to the right testosterone level faster, while they wait for or begin their standard full treatment.
You likely qualify if…
You likely don't qualify if…
You will attend a screening visit within one week where your doctor will review your medical history, take blood tests, check your blood pressure, and get an electrocardiogram. You will then start taking the medication by mouth once daily (with food) along with a low-dose steroid for 30 days. During this time, you'll have one follow-up visit around day 30 to check your testosterone level, PSA level, and for any side effects. After day 30, you will move to your standard cancer treatment as planned by your oncologist.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Argentina
Spain